Although the number of patients receiving anti-TNF treatment in our study was small, we observed that, in daily practice, the number of such patients is considerably higher, and this frequently used drug group requires close monitoring because of its increased risk of developing active tuberculosis. Here, TNF is linked to tuberculosis.